Effect of propranolol on temporomandibular joint pain in repeatedly stressed rats

Abstract

AbstractStress substantially increases the risk of developing painful temporomandibular disorders (TMDs) by influencing the release of endogenous catecholamines. Propranolol, an antagonist of β‐adrenergic receptors, has shown potential in alleviating TMD‐associated pain, particularly when the level of catecholamines is elevated. The aim of this study was to explore whether intra‐articular propranolol administration is effective in diminishing temporomandibular joint (TMJ) pain during repeated stress situations. Additionally, we investigated the effect of repeated stress on the expression of genes encoding β‐adrenoceptors in the trigeminal ganglion. In the present study, rats were exposed to a stress protocol induced by sound, then to the administration of formalin in the TMJ (to elicit a nociceptive response), followed immediately afterward by different doses of propranolol, after which the analgesic response to propranolol was evaluated. We also assessed the levels of beta‐1 and beta‐2 adrenergic receptor mRNAs (Adrb1 and Adrb2, respectively) using reverse transcription–quantitative PCR (RT‐qPCR). Our findings revealed that propranolol administration reduces formalin‐induced TMJ nociception more effectively in stressed rats than in non‐stressed rats. Furthermore, repeated stress decreases the expression of the Adrb2 gene within the trigeminal ganglion. The findings of this study are noteworthy as they suggest that individuals with a chronic stress history might find potential benefits from β‐blockers in TMD treatment.